𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial

✍ Scribed by Boccardo, F.


Book ID
121695154
Publisher
Oxford University Press
Year
2006
Tongue
English
Weight
87 KB
Volume
17
Category
Article
ISSN
0923-7534

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Anastrozole alone or in combination with
✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d